Heron Therapeutics Inc.
Commercial‑stage biotech leveraging proprietary Biochronomer delivery system, offering SUSTOL & CINVANTI for chemotherapy‑induced nausea, ZYNRELEF for pain, and APONVIE for post‑operative N/V—single‑dose regimens addressing unmet oncology & pain markets.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 122
- HQ: Cary
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.